1. Introduction {#sec1}
===============

During early times post-infection, as part of the primary transcription payload, mammalian orthoreovirus (MRV) forms small, membrane-less, punctuated cytosolic inclusions named viral factories (VFs). As the virus protein levels increase with the secondary transcription, the VFs enlarge and localize to the perinuclear area. Several biochemical processes occur within the VFs, such as the synthesis of ss (+) RNAs both for translation and as templates for replicating dsRNA genome segments, which are subsequently packaged in newly formed viral cores. Several MRV proteins compose VFs including μ2, μNS, μNSC, σNS, λ2, μ3 as well as an undetermined number of host proteins such as microtubules (MTs) ([@bib37]), TRiC chaperonin ([@bib24]), dynein ([@bib13]), clathrin ([@bib20]) and HSC70 ([@bib22]). Depending on the virus strain, the VFs are filamentous (e.g., T1L strains) or globular (e.g., T3D^N^); the diversification mainly depends on the ability of minor core protein μ2 to associate with MTs ([@bib9]; [@bib15]; [@bib58]; [@bib37]). Specifically, a μ2 point mutation in Pro 208 to Ser predisposes to the formation of globular VFs ([@bib37]). Additionally, μ2 needs to self-oligomerize for MT-association through aa region 283--325 ([@bib15]). Interestingly, μNS, when expressed in the absence of other viral proteins forms cytosolic inclusions ([@bib5]; [@bib8]) termed VF-like structures (VFLS) that are morphologically identical to globular VFs. When μ2 (T1L; aa region 290--435) interacts with μNS, filamentous VFLSs are formed ([@bib9]; [@bib15]). VFs are highly dynamic structures that coalesce with each other and move to the perinuclear area. These processes require at least dynein as a molecular motor ([@bib13]). Since the study of filamentous VF dynamics turns to be cumbersome, a reconstituted model based on the transfection of different ratios of μ2-and μNS-encoding plasmids (μ2/μNS) allowed providing simplified elements for quantification of diverse motion events. This model mimics different stages of VF dynamics at increasing time post-infection ([@bib13]).

MTs are polarized polymers composed of α- and β-tubulin heterodimers with a length ranging from 1 to 100 μm and dependent on GTP for their assembly. The MTs provide the track for motors allowing the movement of organelles, vesicles, and other structures, which contributes to the efficient functioning of the cells and the organism ([@bib17]). Thus, MTs play a role in the cell organization as they are involved in organelle localization and in establishing cell polarity. MTs undergo a series of post-translational modifications (PTMs), including phosphorylation, acetylation, sumoylation, detyrosination, and polyglutamylation ([@bib21]). While most tubulin PTMs occur on the outer surface of MTs, acetylation has been identified in Lys 40 of α-tubulin, which is exposed at the MT-luminal inner surface ([@bib26]; [@bib27]; [@bib39]; [@bib47]). Drugs such as taxol ([@bib3]) and low temperature stabilize MTs, whereas other drugs such as nocodazole, colchicine, vinblastine, and vincristine depolymerize the MTs ([@bib17]). MT-organizing centers (MTOCs) are the general term for all localized foci of the MT-nucleating machinery, including centrosomes and spindle pole bodies ([@bib51]). MTOCs contain γ-tubulin and the γ-tubulin ring complex (γ-TURC) as well as centrioles and a complex array of other proteins, such as motors and +TIP (MT plus-end tracking protein). The γ-tubulin, present in all eukaryotic organisms, is a key element of the cytoskeleton that nucleates the growth of new MT structures ([@bib56]). It arranges in a helical manner at the edge of the γ-TURC cap to form strong longitudinal contacts with the incoming α-tubulin of αβ-tubulin heterodimers, thereby providing a template for the formation of 13 protofilament MTs ([@bib2]; [@bib25]). Other proteins also have a role in the MT-nucleation. For example, centrin is a main component of centrioles that links MT-doublets and plays a role in both spatial and temporal control over centrioles ([@bib44]). Interestingly, MT-severing enzymes cut pre-existing MTs, creating new MT ends that can serve as γ-TURC-independent platforms for templated MT-nucleation, which appears a relevant process in mammalian neurons, plants, and nematodes ([@bib6]; [@bib28]; [@bib48]).

Here, specific μ2 *punctae* observed in filamentous VFs are investigated concerning their ability to co-localize with other reovirus proteins and host elements. Our study shows that μ2 *punctae* in VFs co-localize with γ-tubulin, are resistant to nocodazole, and permit MT emergence, common features for MTOCs. Moreover, using the VFLS model, we found that specific μ2/μNS ratios that support filamentous morphology relocalize γ-tubulin and centrin to foci within the VFLS. Such association is obliterated upon MT overexpression.

2. Results {#sec2}
==========

2.1. Filamentous viral factories have MTOC-like structures {#sec2.1}
----------------------------------------------------------

Immunofluorescence microscopy of reovirus T1L infected cells at 12 hpi, revealed μ2 *punctae* inside the filamentous VFs ([Fig. 1](#fig1){ref-type="fig"} A). The *punctae* co-localized neither with other viral proteins (μNS, σNS, λ2, σ3, μ1) **(** [Fig. 1](#fig1){ref-type="fig"}B--E **and** [Fig 2](#fig2){ref-type="fig"} A**)** nor with intermediate filaments or dynein intermediate chain (DIC) ([Fig. 2](#fig2){ref-type="fig"}D and E). Co-staining for μ2 and α-tubulin, however, showed bundles of MTs extending from the *punctae*, suggesting that the *punctae* may have a role as MTOCs ([Fig. 2](#fig2){ref-type="fig"}C). Indeed, co-staining for μ2 and γ-tubulin, a conventional marker for centrosomes and other MTOCs ([@bib43]), showed μ2 and γ-tubulin co-localizing in the *punctae* as denoted by immunofluorescence photomicrograph and profile intensities of the linear region of interest (LROI) ([Fig. 2](#fig2){ref-type="fig"}B). Importantly, nocodazole treatment, which is a well-known MT-depolymerizing agent, failed to disrupt the *punctae*, which remained positive for both μ2 and γ-tubulin **(** [Fig. 3](#fig3){ref-type="fig"} A and B**).** Our results show that γ-tubulin localization is intensified in μ2 *punctae* upon nocodazole treatment ([Fig. 3](#fig3){ref-type="fig"}D), consistent with the fact that MTOCs are nocodazole resistant ([@bib42]). Reovirus protein μNS is mainly dispersed from *punctae* when cells are treated with nocodazole ([Fig. 3](#fig3){ref-type="fig"}A), suggesting a mild or no role in μ2 *punctae* formation. As expected, MT bundles depolymerized upon nocodazole treatment **(** [Fig. 3](#fig3){ref-type="fig"}C**)**.Fig. 1μ2 forms *punctae* in T1L induced VF inclusions. CV-1 cells were infected with MRV T1L at an MOI of 10 pfu/cell. At 12 hpi, cells were fixed and immunostained for the detection of μ2 (anti-μ2-Texas red, red), μNS (A), σNS (B), μ1 (C), λ2 (D), and σ3(E) (green). Nuclei were stained with DAPI (blue). The dashed open boxes correspond to the magnified images in the right panel. The yellow arrowheads indicate the position of μ2 *punctae* in VFs. Scale bar is 10 μm. Intensity profile plot of μ2 *punctae* (red line) and indicated proteins (green line) of the linear region of interest (LROI) of images from the corresponding open box of each image panel.Fig. 1Fig. 2γ-tubulin localizes within μ2 puncta. Immunofluorescence of MRV T1L-infected CV-1 cells \[MOI, 10 pfu/cell\]. At 12 hpi, cells were fixed and immunostained for the detection of μ2 (anti-μ2-Texas Red, red), μNS (A) (anti-μNS-Alexa 488, green), γ-tubulin (B) (anti-γ-tubulin, green), MTs (C) (anti-α-tubulin, green), intermediate filaments (D) (anti-vimentin, green) and dynein (E) (anti-dynein intermediate chain (DIC), green). Nuclei were stained with DAPI (blue). The dashed open boxes correspond to the localization of the magnified images in the right panel. The yellow arrowheads indicate the position of μ2 *punctae* in VFs. Scale bar is 10 μm. Intensity profile plot of μ2 *punctae* (red line) and indicated proteins (green line) of the linear region of interest (LROI) of images from the corresponding open box of each image panel.Fig. 2Fig. 3μ2 *punctae* are resistant to nocodazole treatment and co-localize with γ-tubulin. Immunofluorescence of MRV T1L (MOI, 10 pfu/cell)-infected CV-1 cells, either untreated (-NOC, left panel) or treated with 10 μM nocodazole (+NOC, right panel) for 2 h before fixation. At 18 hpi, cells were fixed and immunostained for the detection of μ2 (anti-μ2-Texas red, red), μNS (A) (anti-μNS-Alexa 488, green), γ-tubulin (B) (anti-γ-tubulin, green) and MTs (C) (anti-α-tubulin, green). Nuclei were stained with DAPI (blue). The dashed open white boxes correspond to magnified images in each panel on the middle column. The yellow arrows indicate the position of the μ2 *punctae* in VFs. Scale bar is 10 μm. Intensity profile plot of μ2 *punctae* (red line) and indicated proteins (green line) of the linear region of interest (LROI) of images from the corresponding open box of each image panel. (D) Box plot of relative co-localization to μ2 *punctae* with γ-tubulin untreated (-NOC) or treated with nocodazole (+NOC). Data is presented as median ± quartile; *t*-test, (\*\*\*\*) p\<0.0001, n \>15 μ2 *punctae*.Fig. 3

2.2. MTOC-like structures in filamentous viral factories are nocodazole resistant {#sec2.2}
---------------------------------------------------------------------------------

T1L-infected cells were treated with 10 μM nocodazole from 1 to 12 hpi, a treatment that does not disturb the virus entry process ([@bib13]; [@bib30]; [@bib31]). Nocodazole was then removed from the medium, allowing MTs to re-polymerize for 0, 5, 15, 30, or 60 min before methanol-fixation ([Fig. 4](#fig4){ref-type="fig"} A). Immediately after nocodazole removal (i.e., at 0 min), μ2-*punctae* were observed in the VFs while filamentous μ2 and MTs were not. However, within only 15 min after nocodazole removal, polymerizing MTs with associated μ2 were observed extending from the *punctae* ([Fig. 4](#fig4){ref-type="fig"}B, C, and D). These findings strongly suggest that the *punctae* in the viral factories are functionally MTOC-like and may nucleate MTs and direct MT formation in cells.Fig. 4μ2 *punctae* act as MTOC-like structures. (A) Experimental-design for MT recovery in MRV-infected cells after treatment with nocodazole. (B and C) Immunofluorescence detection of μ2 *punctae* in VF at the indicated times post-recovery after nocodazole treatment. MRV-infected cells were fixed and immunostained for the detection of μ2 (anti-μ2-Texas Red, red), μNS (B) (anti-μNS-Alexa 488, green) and MTs (C) (anti-α-tubulin, green). Nuclei were stained with DAPI (blue). The dashed open white boxes correspond to magnified images in the right panel. The yellow arrows point to the localization of the yellow arrows. Scale bar is 10 μm. Intensity profile plot of μ2 (red line) and α-tubulin (green line) of the linear region of interest of images from nocodazole untreated (top panel), 0 min-- (middle panel) and 5 min-(bottom panel) recovery of nocodazole treatment. (D) Box plot of α-tubulin and μ2 *punctae* prolongation at indicated conditions. Data is presented as median ± quartile; *t*-test, (\*\*\*) p \< 0.001, (\*\*\*\*) p\<0.0001, n \>15 μ2 *punctae*.Fig. 4

2.3. γ-tubulin and centrin form *punctae* within μ2(T1L)/μNS-VFLSs {#sec2.3}
------------------------------------------------------------------

We recently described that the reconstitution of VFLS upon transfection of expression plasmids encoding μ2 (T1L) and μNS at different ratios (μ2/μNS) may serve as a model for studying temporal dynamics of VFs ([@bib13]). MTOCs are visualized as two *punctae* at a juxtanuclear position during interphase ([@bib29]; [@bib45]). Under this consideration, we investigated the localization of two specific markers for MTOCs, specifically γ-tubulin **(** [Fig. 5](#fig5){ref-type="fig"} **)** and centrin **(** [Fig. 6](#fig6){ref-type="fig"} **)**. As expected, at non-transfected (NT) conditions, both γ-tubulin and centrin localized to well-featured MTOCs corresponding to two polarized *punctae* at the perinuclear area **(** [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"} **, lower row)**. Similarly, γ-tubulin and centrin in cells containing VFLS formed at ratios 2:0, 2:4, and 0:4 of μ2/μNS **(** [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"} **, first, fourth, and fifth rows)** mainly localized in MTOCs. In contrast, γ-tubulin and centrin localized to defined *punctae* in VFLS reconstituted with μ2/μNS transfection ratios of 2:1 and 2:2 **(** [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"} **, second and third rows)**. To evaluate if γ-tubulin and centrin *punctae* increment in number and redistribute to VFLSs generated with different μ2/μNS ratios, we first quantified cells with more than two γ-tubulin *punctae*. As denoted in [Fig. 7](#fig7){ref-type="fig"} A, a significantly higher percentage of cells containing \>2 MTOCs is observed at 2:1 and 2:2 transfection ratios of μ2 (T1L)/μNS when compared to the other ratios. Similar results were obtained when quantifying the localization of centrin labeled *punctae* ([Fig. 7](#fig7){ref-type="fig"}B). To analyze the redistribution of MTOC-like *punctae*, we performed three-dimensional (3D) reconstructions of Z-stack images acquired by high definition confocal microscopy. The 3D-reconstruction VFLSs formed with μ2 (T1L)/μNS at transfection ratio of 2:1 ([Fig. 7](#fig7){ref-type="fig"}C, C′ and C″) showed that centrin *punctae* co-localize with the μ2 signal in VFLS, suggesting the redistribution of the MTOC-like *punctae* among VFLSs. Interestingly, μ2 association to MTs role seems pre-requisite since μ2 (T3D^N^)/μNS VFLS is defective for γ-tubulin recruitment when compared to μ2 (T1L)/μNS VFLS at any of the studied ratios ([Fig. S1](#appsec1){ref-type="sec"}).Fig. 5γ-tubulin redistributes into VFLSs. Confocal maximum intensity projection of VFLSs immunofluorescence composed of the indicated transfection ratios μ2 and μNS expression plasmids. At 24 hpt, CV-1 cells were fixed with methanol and immunostained with specific antibodies for the detection of μ2 (red), μNS (green), and γ-tubulin (cyan). Nuclei were stained with DAPI (blue). The third column shows a merged image. The dashed white open boxes correspond to magnified images in the fourth column. White arrowheads point to γ-tubulin localization. NT, non-transfected cells. Scale bar is 10 μm.Fig. 5Fig. 6Centrin redistributes into VFLSs. Confocal maximum intensity projection of VFLSs immunofluorescence. At 24 hpt, CV-1 cells were fixed with methanol and immunostained with specific antibodies for the detection of μ2 (red), μNS (green), and centrin (cyan). Nuclei were stained with DAPI (blue). The third column shows a merged image. The dashed white open boxes correspond to magnified images in the fourth column. White arrowheads point to γ-tubulin localization. NT, non-transfected cells. The μ2/μN transfection ratios are indicated. Scale bar is 10 μm.Fig. 6Fig. 7MTOCs in VFLS increase in number at a specific μ2/μNS ratio. (A and B) The plot of the percentage of cells showing more than two MTOC-like structures (\>2 MTOCs) at each of the indicated ratios of the μ2 and μNS expression plasmids. \>75 cells per sample were analyzed. T-test, (\*\*\*) p \< 0.001. Confocal maximum intensity projection (C) and three-dimensional reconstruction (C′, C″) of immunofluorescence staining of VFLS at a μ2/μNS transfection ratio of 2:1. At 24 hpt, CV-1 cells were fixed and immunostained for the detection of μ2 (anti-μ2, red), μNS (anti-μNS, green) and centrin (C, C′ and C″) (anti-centrin, cyan). Three-dimensional reconstruction top (C′) and bottom (C″) show localization of γ-tubulin or centrin with μ2 and nucleus. White arrows point to γ-tubulin and centrin *punctae*. Scale bar is 5 μm. (D) Immunoblot of nickel resin pulled-down extract from cells co-expressing γ-tubulin-HA, μ2-histidine-tagged (H~6X~-μ2), and μNS (ce, cellular extract input; ft, flow-through; el, column eluate). The ratios of transfected μ2-H~6X~ and μNS expression plasmids are indicated. (−) cell expressing only γ-tubulin-HA. The membranes were incubated with anti-μ2 (upper panel), anti-μNS (middle panel) and anti-HA (lower panel).Fig. 7

Consistent with our results, γ-tubulin-HA was pulled down from an extract of cells previously transfected with expression plasmids encoding HA-tagged γ-tubulin and μ2-H~6X~ (histidine tag)/μNS at a transfection ratio of 2:1 **(** [Fig. 7](#fig7){ref-type="fig"}D**, lane 6)**. Meanwhile, weak or no association of γ-tubulin-HA was observed at transfection ratios 2:0, 2:2, and 2:4 **(** [Fig. 7](#fig7){ref-type="fig"}D**, lanes 3, 9, and 12)**.

2.4. Centrin *punctae* in VFLS delocalize upon MT-overexpression {#sec2.4}
----------------------------------------------------------------

Next, we investigated whether MT-overexpression reduces MTOC-like localization in VFLSs. For this purpose, we over-expressed β-tubulin-mCherry ([@bib32]) or mCherry in cells with VFLSs reconstituted with a μ2/μNS transfection ratio of 2:1. We used this specific μ2 (T1L)/μNS VFLS ratio because the above experiments ([Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}) indicated more MTOC-like structures among VFLS**.** As observed in [Fig. 8](#fig8){ref-type="fig"} A, when VFLSs are reconstituted with a μ2 (T1L)/μNS transfection ratio of 2:1, the over-expression of MTs (β-tubulin-mCherry) resulted in a significant decrease in the percentage of cells containing \>2 MTOCs when compared with the control (mCherry). Interestingly, the expression of β-tubulin-mCherry or mCherry did not alter the number of MTOCs in cells with no VFLSs (NT) (data not shown). Also, VFLSs composed of μNS only were not affected by the increasing number of MTs. Moreover, as denoted in [Fig. 8](#fig8){ref-type="fig"}B, an increase in MTs (β-tubulin-mCherry) seems to favor the perinuclear condensation of VFLS compared to the mCherry control. Consistent with a previous report ([@bib13]), the perinuclear condensation of VFLS composed only of μNS was not impaired by an increase in the number of MTs. This outcome confirms that μNS plays no role in VF perinuclear condensation.Fig. 8β-tubulin-mCherry overexpression impairs the re-localization of centrin into VFLS. At 24 hpt, CV-1 cells expressing μ2, μNS, and β-tubulin-mCherry or mCherry were fixed and immunostained for μ2 and μNS, processed for data acquisition hand quantified as described in Materials and Methods. (A) plot of the percentage of μ2/μNS transfected cells with more than two MTOCs per cell when co-expressed with β-tubulin-mCherry (tub-mCherry) (black bars) or mCherry (white bars). (B) Plot for perinuclear condensation of VFLSs at the indicated μ2/μNS ratios when co-expressed with β-tubulin-mCherry (black bars) or mCherry (white bars). All data is presented as mean ± SEM, t-student test, two tail paired, (\*\*\*) p \< 0.0001, (ns) p \> 0.05; number \>70 cells.Fig. 8

3. Discussion {#sec3}
=============

The formation of μ2 *punctae* in filamentous VFs is not a novel observation; these structures have been described previously as putative replication centers in VFs ([@bib37]). However, μ2 *punctae* linked to the MRV replication center were indirectly supported by the μ2 functions as structural minor core protein ([@bib12]; [@bib54]), NTPase ([@bib36]), and RTPase ([@bib23]). Here, we show evidence that μ2 *punctae* instead are MTOC-like structures recruiting γ−tubulin and centrin to the VFs. The μ2 *punctae* did neither co-localize properly with any of the other MRV proteins that are VF components nor with α-tubulin or dynein intermediate chain, which are known host components of VFs ([@bib13]; [@bib37]). The resistance of the μ2 *punctae* to nocodazole treatment, an MT-depolymerizing drug, is a well-established feature of MTOC-like structures ([@bib56]). Another MTOC behavior is the ability to nucleate MTs ([@bib25]). We show that cells reconstituted from nocodazole treatment supported MT-reemergence from μ2 *punctae*. Indeed, as μ2 directly associated with MTs ([@bib23]), it also reemerged with MTs from the VF MT-nucleation center. Interestingly, our data is consistent with the presence of μ2 *punctae* in globular VFs formed, e.g., in strain T3D^N^, since μ2 of this strain cannot associate with MTs ([@bib9], [@bib8]; [@bib15], [@bib13]; [@bib34]; [@bib37]) but could still interact with MTOC components as γ-tubulin. As described previously ([@bib13]), globular VF dynamics are also dependent on intact MT-network, including MT-nucleation and orientation. Since μ2 (T3D^N^) VFLSs show defective γ-tubulin recruitment, it suggests *i)* the requirement, aside from μNS, of other host or viral components and *ii)* MT-association region of μ2 is not sufficient for γ-tubulin recruitment. This topic is currently under investigation in our laboratory. These outcomes are also consistent with the VFLS simplified model using different μ2 (T1L)/μNS expression plasmid ratios, which allowed us to determine that a reduced amount of μNS is required for the recruitment γ-tubulin and centrin. This outcome is not surprising since it has previously been demonstrated that μNS stabilizes the μ2-MT association ([@bib13]). However, μNS is unable to recruit the MTOC components into VFLS, suggesting a predominant role of μ2. These results have been demonstrated by employing high definition confocal immunofluorescence microscopy, quantification of MTOCs, and pull-down of γ−tubulin-HA, and consistently revealed that a μ2/μNS expression plasmid ratio of 2:1 supports both MT nucleation in VFLSs and association with γ-tubulin. An overexpression of MTs, as obtained upon transfection of β-tubulin-mCherry, impaired the MT-nucleation in VFLS even at a μ2/μNS ratio of 2:1, indicating a competence between μ2 and host components for the association to MTOC components. Interestingly, VFLSs at ratio 2:1 condensate at the perinuclear region faster when MTs are overexpressed than in control conditions (mCherry). This effect is explained by favoring the direct association of μ2-MT ([@bib15]; [@bib37]) over the μ2/μNS association ([@bib13]; [@bib33]). Thus, it has been described that VFLS composed of μ2 only condenses better at the perinuclear area than VFLS generated μ2/μNS transfection ratio 2:1 ([@bib13]). Here, we also show that the μ2-VFLS (ratio 2:0) preserves the juxtanuclear MTOC position, indicating that μ2 may associate with MT and move towards MT with the help of an unknown kinesin. As expected and consistent with our previous work ([@bib13]), μNS VFLS (ratio 0:4) did not alter its localization in the presence of an excess of MT confirming no MT-association.

Importantly, filamentous MRV is not the first case of MTOC subversion. Several viruses have usurped MTOCs properties to favor their replication. For example, human cytomegalovirus (HCMV) forms a Golgi based MT-nucleation center to facilitate virus assembly ([@bib40]). Herpes simplex virus-1 favors non-centrosomal MT nucleation to promote efficient virus spread ([@bib38]). Human immunodeficiency virus (HIV-1) accumulates MTOCs at the pre-integration step, elongating the centrosomes and recruiting γ-tubulin by a role attributed to Vpr ([@bib18]). Other viruses, such as poxviruses or African swine fever virus (ASFV), create VFs at MTOCs ([@bib55]). β-coronaviruses, including SARS-CoV, adapt their replication vesicles surrounding MTOCs ([@bib4]). However, this is the first report showing that cytosolic membrane-less factories can recruit MT-nucleation centers. These MTOC-like structures are mainly found in the enlarged globular part of the filamentous VFs. Thus, several roles could be attributed to MTOC-like structures: i) support of genome packing by MT-network ([@bib46]) and ii) transition of VFs towards the perinuclear region to favor interchanges with the nucleus. In this sense, μ2 has been described to localize in the nucleus ([@bib57]) and to trigger innate immunity ([@bib19]; [@bib49]). These exciting alternatives require further investigation.

In summary, μ2 *punctae* behave like MTOCs by nucleating MTs into VFs. Also, MTOCs standard markers, γ-tubulin, and centrin get recruited into both VFs and VFLSs. The VF matrix μNS did not have a direct role in μ2 *punctae* formation; however, it supported MTOC components, at least in a VFLS model.

4. Materials and methods {#sec4}
========================

4.1. Cells and viruses {#sec4.1}
----------------------

CV-1 cells (African green monkey fibroblasts) were obtained from Max L. Nibert\'s stock and cultured in Dulbecco\'s modified Eagle\'s medium (Invitrogen) supplemented with 10% fetal bovine serum \[ANIMEB, Bioconcept, Switzerland\] and penicillin/streptomycin. MRV strain T1L and T3D^N^ was obtained from the Bernard N. Fields collection, kindly provided by Max L. Nibert (Harvard Medical School, Boston, MA). Viral titers were determined by plaque assay using L-cell monolayer ([@bib50]). T~7~ RNA polymerase recombinant vaccinia virus (strain vvT7.3) was amplified, and viral titer determined as described previously ([@bib16]).

4.2. Antibodies and reagents {#sec4.2}
----------------------------

Rabbit polyclonal antisera specific for μ2 and μNS were used as described previously ([@bib37]; [@bib41]). Rabbit polyclonal anti-μNS conjugated to Alexa 488 and rabbit polyclonal anti-μ2 conjugated to Texas-red were described previously ([@bib8]). Mouse monoclonal antibody (mAb) anti-σNS (3E1) ([@bib7]), mouse mAb anti-μ1 (clone 10H2) ([@bib11]), mouse mAb anti-λ2 (clone 7F4) ([@bib52]), and mouse mAb anti-σ3 (clone 5C3) ([@bib9]) were published previously. Mouse mAb anti-γ-tubulin (C-11) and mouse anti-vimentin were purchased from Santa Cruz Biotechnology. Mouse mAb anti-centrin (clone 20H5) was purchased from Millipore. Mouse mAb anti-α-tubulin (clone B-5-1-2), mouse monoclonal anti-dynein intermediate chain (clone 70.1), mouse mAb anti-γ-tubulin (clone GTU-88) and mouse anti-HA (clone HA-7) were purchased from Sigma-Aldrich. Goat anti-mouse immunoglobulin G (IgG) conjugated to Alexa 488, goat anti-rabbit IgG conjugated to Alexa 594, and goat anti-mouse IgG conjugated to Alexa 647, were obtained from Molecular Probes, Invitrogen. Nocodazole was purchased at Sigma-Aldrich.

4.3. DNA plasmids {#sec4.3}
-----------------

pCI-μ2 (T1L), pCI-μ2 (T3D^N^), and pCI-μNS(T1L) were previously described ([@bib9]; [@bib37]). pCI-μ2 (T1L)-H~6X~ was obtained by PCR amplification of pCI-μ2 (T1L)-HA ([@bib15]) using specific primers to insert flanking *Xho*I/histidine tag-*Not*I sites, followed by ligation between the *Xho*I and *Not*I sites of pCI-Neo (Promega). pcDNA-γ-tubulin-HA was obtained by PCR amplification of pcDNA-human γ-tubulin-EGFP using specific primers to insert flanking *Xho*I/HA-tag-*Not*I sites, followed by ligation in those sites in pCI-Neo (Promega). pcDNA-human γ-tubulin-EGFP was kindly provided by Karl Munger (Harvard Medical School, Boston, MA, USA) ([@bib35]). pCI-β-tubulin-mCherry was obtained by PCR amplification of β-tubulin from pTUBB-EGFP ([@bib1]), kindly provided by Urs Greber (University of Zurich, Zurich, Switzerland), using specific primers to insert flanking *EcoR*I/*Sal*I restriction sites, followed by ligation in those sites in pCI-mCherry-stop. pCI-mCherry-stop was obtained by PCR amplification of pBS-TasA-mCherry ([@bib53]) with specific primers to insert in-frame *Sal*I and STOP codon/*Xma*I, followed by ligation in those sites in pCI-Neo.

All of the oligonucleotides were obtained from Microsynth AG, Switzerland, and the sequences are available upon request.

4.4. Immunofluorescence {#sec4.4}
-----------------------

CV-1 cells were seeded the day before transfection or infection at a density of 1 × 10^5^ cells per well into 24 multiwell-plates. Cells were transfected with lipofectamine®2000 (Life Technologies) as described previously by ([@bib13]). For infection of cell monolayers, an MOI of 10 pfu per cell was used. The virus was adsorbed for 1 h at 4 °C, and then DMEM containing 2% FBS was added. Cells were incubated at 37 °C for the indicated times post-infection. When indicated, cells were fixed in cold methanol for 3 min at − 20 °C. Coverslips were permeabilized for 5 min in PBS \[137 mM NaCl, 3 mM KCl, 8 mM Na~2~HP0~4~, 1 mM KH~2~P0~4~ pH 7.5\] containing 0.1% Triton X-100 and blocked for 30 min in PBS containing 1% bovine serum albumin (BSA) for 20 min. Antibodies were diluted in 1% BSA-PBS and incubated for 45 min at room temperature in a humidified chamber. Nuclei were stained with 70 nM 4,6-diamino-2-phenylindole (DAPI) (Molecular Probes, Invitrogen, USA). Cells were mounted in Prolong Gold (Molecular Probes). Images were acquired using a CSLM (Leica, DM 5500Q) equipped with 63 × 1.3 oil objective or a Nikon Eclipse TE 2000-U fluorescence microscope. The data were analyzed and processed with Leica Application Suite (Mannheim, Germany), the Imaris software package (Bitplane, Switzerland), and ImageJ version 2.0.0-rc69/1.52p.

The intensity profile of a linear region of interest (LROI) was obtained using the ImageJ plot profile tool. The data were plotted using Microsoft Excel for MAC version 16.37. The co-localization value was obtained by calculating the area below the curve of intensity profiles of both μ2 *punctae*-prolongations and other proteins. For this purpose, the Image J magic wand tool was used to provide the grey value intensity for each point, from which a protein signal percentage was obtained on the occupied μ2 *punctae-*prolongation area below the curve. The average value of untreated samples was considered as value of 1 to determine the relative co-localization to μ2-*punctae*. For confocal data, maximum intensity projections were obtained from Z-stack images acquired by high-resolution CLSM. Subsequently, 3D-reconstructions were performed using surface and filament algorithms from the surpass model of the Imaris 7.0 software (Bitplane, Switzerland). Images were prepared for publication using Microsoft®PowerPoint® 2019 for MAC, version 16.35.

4.5. Determination of perinuclear condensation and quantification of MTOC structures {#sec4.5}
------------------------------------------------------------------------------------

The condensation of the VFLS to the perinuclear region was expressed as \[(F--N)/N\] ratio, where F is the area of distribution of the VFs and N is the nuclear area determined using Image J version 2.0.0-rc69/1.52p. For the quantification of MTOCs, confocal maximum intensity projection images were used to sort cells showing VFLS with more than two MTOC like structures. Values, statistical analysis, and two tail-paired Student\'s tests were performed with Microsoft® Excel 2019 for MAC, version 16.35, as described previously ([@bib14]).

4.6. Pull-down assay {#sec4.6}
--------------------

1.5 × 10^6^ CV-1 cells were infected with vvT7.3 at an MOI of 10 pfu/cell before transfection with 1 μg pCI-γ-tubulin-HA, 0.5 μg pCI-μ2 (T1L)-H~6X~ and 0.25--1 μg pCI-μNS(T1L) using 18 μl lipofectamine® 2000 (Life Technologies) according to the manufacturer instructions. At 15 hpt, cells were crosslinked with 600 μM dithiol (succinimidyl propionate) in PBS for 20 min on ice. Cells were incubated twice with quenching buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl) for 3 min on ice. The cell lysates were prepared in 180 μl of TNN buffer (100 mM Tris-HCl pH 8.0, 250 mM NaCl, 0.5% NP-40, 1X HALT phosphatase inhibitor cocktail (Thermo Fischer Scientific) and cOmplete™ protease inhibitor cocktail (Roche)) as described previously ([@bib10]). The cellular extract was loaded onto 50 μl of PerfectPro Ni-NTA agarose (5 PRIME, Germany) equilibrated in 25 mM imidazole in PBS. Samples were processed and analyzed, as described by ([@bib15]).
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Appendix A. Supplementary data {#appsec1}
==============================

The following is the Supplementary data to this article:Figure S1. γ-tubulin is less distributed into μ2(T3D^N^) VFLSs than μ2(T1) VFLD. Confocal immunofluorescence of VFLSs composed of (A) the indicated cognate transfection ratios μ2 (T3D^N^)/μNS (T1L) (left panel) and μ2 (T1L)/μNS(T1L) expression plasmids. (B) At 24 hpt, cells expressing μNS (T1L) VFLS (left panel) and non-transfected (NT, right panel) were paraformaldehyde fixed and immunostained with specific antibodies for the detection of μ2 (red), μNS (green), and γ-tubulin (cyan). Nuclei were stained with DAPI (blue). The first and third columns show a merged image. The dashed white open boxes correspond to magnified images in the second and fourth columns. White arrowheads point to γ-tubulin localization. NT, non-transfected cells. Scale bar is 10 μm.
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